NasdaqGM - Nasdaq Real Time Price USD
Larimar Therapeutics, Inc. (LRMR)
2.2050
-0.0450
(-2.00%)
At close: June 2 at 4:00:01 PM EDT
2.2500
+0.05
+(2.04%)
After hours: June 2 at 6:12:06 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | -0.49 | -0.51 | -1.95 | -1.75 |
| Low Estimate | -0.51 | -0.56 | -2.12 | -2.57 |
| High Estimate | -0.46 | -0.47 | -1.83 | -0.86 |
| Year Ago EPS | -0.34 | -0.24 | -1.32 | -1.95 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 10 | 9 |
| Avg. Estimate | -- | -- | -- | 8.21M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 43.7M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.32 | -0.37 | -0.32 | -0.41 |
| EPS Actual | -0.34 | -0.24 | -0.45 | -0.46 |
| Difference | -0.02 | 0.13 | -0.13 | -0.05 |
| Surprise % | -7.79% | 35.20% | -40.88% | -12.43% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.49 | -0.51 | -1.95 | -1.75 |
| 7 Days Ago | -0.48 | -0.5 | -1.95 | -1.8 |
| 30 Days Ago | -0.45 | -0.47 | -1.81 | -1.77 |
| 60 Days Ago | -0.4 | -0.44 | -1.66 | -1.7 |
| 90 Days Ago | -0.4 | -0.44 | -1.66 | -1.7 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | 2 | 2 |
| Up Last 30 Days | 1 | -- | 2 | 2 |
| Down Last 7 Days | 3 | 2 | 4 | 3 |
| Down Last 30 Days | 3 | 2 | 4 | 3 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| LRMR | -43.80% | -111.23% | -48.08% | 10.27% |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.96% |
Upgrades & Downgrades
| Reiterates | Guggenheim: Buy to Buy | 3/25/2025 |
| Maintains | Baird: Outperform to Outperform | 3/25/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/25/2025 |
| Initiated | Truist Securities: Buy | 1/29/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/24/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/17/2024 |
Related Tickers
JSPR Jasper Therapeutics, Inc.
5.45
-0.91%
LXEO Lexeo Therapeutics, Inc.
2.7200
0.00%
DAWN Day One Biopharmaceuticals, Inc.
7.01
+9.87%
AUTL Autolus Therapeutics plc
1.9100
+9.14%
ATYR aTyr Pharma, Inc.
4.7500
+6.26%
RZLT Rezolute, Inc.
4.2250
+2.55%
TRVI Trevi Therapeutics, Inc.
6.32
-3.00%
ERAS Erasca, Inc.
1.4250
+1.79%
SLDB Solid Biosciences Inc.
3.5400
+10.28%
VTYX Ventyx Biosciences, Inc.
2.0400
+20.00%